Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Growth Hormone | 134 | 2023 | 705 | 8.210 |
Why?
|
Human Growth Hormone | 46 | 2023 | 683 | 5.200 |
Why?
|
Ghrelin | 19 | 2023 | 266 | 4.260 |
Why?
|
Growth Hormone-Releasing Hormone | 87 | 2023 | 213 | 4.020 |
Why?
|
Insulin-Like Growth Factor I | 69 | 2022 | 2015 | 3.200 |
Why?
|
Acromegaly | 47 | 2018 | 346 | 2.510 |
Why?
|
Receptors, Somatotropin | 16 | 2017 | 76 | 1.910 |
Why?
|
Dwarfism, Pituitary | 8 | 2022 | 46 | 1.480 |
Why?
|
Pituitary Gland | 20 | 2015 | 665 | 1.430 |
Why?
|
Bromocriptine | 18 | 2018 | 111 | 1.410 |
Why?
|
Pituitary Neoplasms | 30 | 2018 | 1345 | 1.360 |
Why?
|
Pituitary Gland, Anterior | 30 | 1998 | 177 | 1.280 |
Why?
|
Fasting | 21 | 2015 | 1593 | 1.060 |
Why?
|
Receptors, Pituitary Hormone-Regulating Hormone | 7 | 2002 | 14 | 0.780 |
Why?
|
Receptors, Neuropeptide | 7 | 2002 | 111 | 0.730 |
Why?
|
Prolactin | 34 | 1997 | 669 | 0.700 |
Why?
|
Spiro Compounds | 5 | 2008 | 76 | 0.680 |
Why?
|
Hydrocortisone | 17 | 2014 | 1826 | 0.660 |
Why?
|
Antiparkinson Agents | 2 | 2018 | 184 | 0.640 |
Why?
|
Circadian Rhythm | 25 | 2014 | 2624 | 0.620 |
Why?
|
Dopamine Agonists | 4 | 2018 | 355 | 0.590 |
Why?
|
Hypoglycemia | 3 | 2022 | 861 | 0.570 |
Why?
|
Aging | 13 | 2023 | 8664 | 0.530 |
Why?
|
Acyltransferases | 2 | 2015 | 294 | 0.530 |
Why?
|
Central Nervous System Cysts | 1 | 2015 | 58 | 0.510 |
Why?
|
Luteinizing Hormone | 24 | 1996 | 869 | 0.500 |
Why?
|
Body Composition | 9 | 2013 | 2401 | 0.490 |
Why?
|
Blood Glucose | 24 | 2015 | 6256 | 0.490 |
Why?
|
Caprylates | 1 | 2015 | 111 | 0.480 |
Why?
|
Peptide Fragments | 26 | 2004 | 5097 | 0.480 |
Why?
|
Muscle, Skeletal | 10 | 2010 | 4931 | 0.460 |
Why?
|
Dwarfism | 5 | 2004 | 146 | 0.440 |
Why?
|
Muscular Atrophy | 4 | 2009 | 349 | 0.410 |
Why?
|
Sermorelin | 4 | 2005 | 4 | 0.390 |
Why?
|
Periodicity | 7 | 1996 | 363 | 0.390 |
Why?
|
Watchful Waiting | 1 | 2015 | 492 | 0.390 |
Why?
|
Indoles | 5 | 2008 | 1839 | 0.380 |
Why?
|
Adenoma | 15 | 2011 | 2174 | 0.380 |
Why?
|
Pituitary Hormones, Anterior | 8 | 1998 | 65 | 0.360 |
Why?
|
RNA, Messenger | 14 | 2012 | 13033 | 0.360 |
Why?
|
Somatomedins | 12 | 1998 | 192 | 0.360 |
Why?
|
Drug Discovery | 1 | 2018 | 1058 | 0.360 |
Why?
|
Acylation | 6 | 2015 | 107 | 0.360 |
Why?
|
Disease | 2 | 2011 | 680 | 0.350 |
Why?
|
Cholecystokinin | 1 | 2010 | 114 | 0.350 |
Why?
|
Somatostatin | 16 | 2005 | 459 | 0.350 |
Why?
|
Benzazepines | 3 | 1997 | 326 | 0.350 |
Why?
|
Insulin | 22 | 2014 | 6580 | 0.340 |
Why?
|
PPAR delta | 1 | 2008 | 43 | 0.330 |
Why?
|
Hormone Replacement Therapy | 3 | 2016 | 745 | 0.320 |
Why?
|
Endocrine System | 1 | 2008 | 113 | 0.310 |
Why?
|
Cattle | 6 | 2007 | 3922 | 0.300 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2010 | 340 | 0.300 |
Why?
|
Growth Disorders | 9 | 1990 | 645 | 0.300 |
Why?
|
Oligopeptides | 8 | 2002 | 1189 | 0.300 |
Why?
|
Consensus | 2 | 2016 | 2959 | 0.300 |
Why?
|
Male | 166 | 2016 | 350118 | 0.290 |
Why?
|
Pituitary Hormone-Releasing Hormones | 4 | 1987 | 41 | 0.280 |
Why?
|
Tetrazoles | 3 | 1997 | 835 | 0.280 |
Why?
|
Receptors, G-Protein-Coupled | 3 | 2013 | 1222 | 0.270 |
Why?
|
Humans | 205 | 2023 | 744343 | 0.260 |
Why?
|
Adult | 128 | 2016 | 214055 | 0.260 |
Why?
|
Societies, Medical | 3 | 2015 | 3743 | 0.260 |
Why?
|
11-beta-Hydroxysteroid Dehydrogenases | 1 | 2004 | 6 | 0.260 |
Why?
|
Adrenocorticotropic Hormone | 10 | 2014 | 648 | 0.250 |
Why?
|
Arginine | 6 | 2008 | 944 | 0.250 |
Why?
|
Longevity | 2 | 2009 | 1070 | 0.240 |
Why?
|
Parkinson Disease | 2 | 2018 | 2775 | 0.240 |
Why?
|
Receptors, Cell Surface | 4 | 2000 | 2866 | 0.240 |
Why?
|
Pituitary Irradiation | 3 | 2003 | 17 | 0.240 |
Why?
|
Adipose Tissue | 6 | 2008 | 3279 | 0.240 |
Why?
|
Endocrinology | 4 | 2015 | 443 | 0.240 |
Why?
|
Peptide Hormones | 1 | 2004 | 134 | 0.230 |
Why?
|
Hypothalamus | 5 | 2004 | 1063 | 0.230 |
Why?
|
Neurosecretory Systems | 2 | 1995 | 231 | 0.220 |
Why?
|
Liver | 5 | 2004 | 7474 | 0.220 |
Why?
|
Fatty Acids | 2 | 2010 | 1809 | 0.220 |
Why?
|
Estradiol | 10 | 2001 | 2020 | 0.220 |
Why?
|
Gonadotropin-Releasing Hormone | 9 | 1992 | 1205 | 0.220 |
Why?
|
Fatty Acids, Nonesterified | 6 | 2015 | 402 | 0.220 |
Why?
|
Tyrosine | 4 | 2009 | 1461 | 0.210 |
Why?
|
Pulsatile Flow | 8 | 2000 | 332 | 0.210 |
Why?
|
Adipocytes | 2 | 2007 | 1184 | 0.210 |
Why?
|
Glucagon | 4 | 2022 | 533 | 0.210 |
Why?
|
Sheep | 3 | 2001 | 1437 | 0.210 |
Why?
|
Mice, Mutant Strains | 5 | 2004 | 1866 | 0.200 |
Why?
|
Infusions, Intravenous | 9 | 2014 | 2274 | 0.200 |
Why?
|
Sleep Stages | 5 | 1998 | 686 | 0.200 |
Why?
|
Injections, Subcutaneous | 9 | 2014 | 666 | 0.200 |
Why?
|
Forkhead Transcription Factors | 1 | 2008 | 1613 | 0.200 |
Why?
|
Gastric Mucosa | 1 | 2004 | 599 | 0.200 |
Why?
|
Pituitary Diseases | 4 | 2007 | 141 | 0.190 |
Why?
|
Aged | 46 | 2023 | 163280 | 0.190 |
Why?
|
Thyrotropin | 14 | 1998 | 849 | 0.180 |
Why?
|
Animals | 50 | 2018 | 168757 | 0.180 |
Why?
|
Receptors, Neurotransmitter | 2 | 1993 | 178 | 0.180 |
Why?
|
Follicle Stimulating Hormone | 10 | 1996 | 744 | 0.180 |
Why?
|
Polyethylene Glycols | 1 | 2005 | 1182 | 0.180 |
Why?
|
Caloric Restriction | 3 | 2012 | 302 | 0.170 |
Why?
|
Recombinant Proteins | 8 | 2015 | 6622 | 0.170 |
Why?
|
Dose-Response Relationship, Drug | 20 | 2004 | 10943 | 0.170 |
Why?
|
Adolescent | 35 | 2016 | 85781 | 0.170 |
Why?
|
Mice, Transgenic | 6 | 2008 | 9734 | 0.160 |
Why?
|
Ergotism | 1 | 2018 | 4 | 0.160 |
Why?
|
Adenoma, Islet Cell | 3 | 1982 | 82 | 0.160 |
Why?
|
Female | 110 | 2016 | 380194 | 0.160 |
Why?
|
Sodium Chloride | 4 | 2014 | 625 | 0.160 |
Why?
|
Obesity | 5 | 2015 | 12745 | 0.160 |
Why?
|
Reference Values | 16 | 2009 | 4982 | 0.160 |
Why?
|
Kinetics | 18 | 1998 | 6473 | 0.160 |
Why?
|
Radioimmunoassay | 13 | 2010 | 919 | 0.160 |
Why?
|
Hormone Antagonists | 1 | 2018 | 108 | 0.160 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2005 | 4751 | 0.150 |
Why?
|
Rats, Inbred Strains | 14 | 1992 | 2186 | 0.150 |
Why?
|
Anniversaries and Special Events | 1 | 2018 | 89 | 0.150 |
Why?
|
Cross-Linking Reagents | 3 | 2001 | 694 | 0.150 |
Why?
|
Rats | 28 | 2013 | 24260 | 0.150 |
Why?
|
Cloning, Molecular | 2 | 2001 | 4320 | 0.150 |
Why?
|
Hyperprolactinemia | 1 | 2018 | 129 | 0.150 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2007 | 2938 | 0.150 |
Why?
|
Injections, Intravenous | 12 | 1998 | 1420 | 0.150 |
Why?
|
Awards and Prizes | 2 | 1998 | 375 | 0.140 |
Why?
|
Administration, Oral | 7 | 2008 | 3913 | 0.140 |
Why?
|
History, 20th Century | 3 | 2018 | 2740 | 0.140 |
Why?
|
Ergolines | 4 | 1981 | 61 | 0.140 |
Why?
|
Health Status | 1 | 2009 | 4034 | 0.140 |
Why?
|
Species Specificity | 4 | 2005 | 2478 | 0.130 |
Why?
|
Osmolar Concentration | 5 | 1998 | 683 | 0.130 |
Why?
|
Thyrotropin-Releasing Hormone | 7 | 1985 | 147 | 0.130 |
Why?
|
Glucocorticoids | 1 | 2004 | 2107 | 0.130 |
Why?
|
Middle Aged | 63 | 2016 | 213383 | 0.130 |
Why?
|
Polymorphism, Genetic | 1 | 2005 | 4328 | 0.120 |
Why?
|
Luminescent Measurements | 6 | 2002 | 405 | 0.120 |
Why?
|
Young Adult | 10 | 2023 | 56430 | 0.120 |
Why?
|
Nutritional Physiological Phenomena | 2 | 1997 | 370 | 0.120 |
Why?
|
Cyclic AMP | 5 | 2001 | 1472 | 0.120 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 2 | 2008 | 123 | 0.120 |
Why?
|
Frail Elderly | 2 | 2009 | 693 | 0.120 |
Why?
|
Receptors, Ghrelin | 3 | 2013 | 25 | 0.120 |
Why?
|
Appetite Regulation | 1 | 2014 | 88 | 0.120 |
Why?
|
Osteoporosis | 1 | 2023 | 1580 | 0.120 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 5 | 1998 | 424 | 0.110 |
Why?
|
Pancreatic Neoplasms | 11 | 1999 | 5256 | 0.110 |
Why?
|
Testosterone | 10 | 2008 | 2420 | 0.110 |
Why?
|
Hormones | 5 | 2023 | 889 | 0.110 |
Why?
|
Double-Blind Method | 10 | 2014 | 12026 | 0.110 |
Why?
|
Hormones, Ectopic | 4 | 1989 | 40 | 0.110 |
Why?
|
Food | 3 | 2014 | 771 | 0.110 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 1994 | 374 | 0.110 |
Why?
|
Mice | 13 | 2013 | 81183 | 0.110 |
Why?
|
Child | 20 | 2022 | 77709 | 0.110 |
Why?
|
Education | 1 | 2015 | 543 | 0.110 |
Why?
|
Eating | 3 | 2005 | 1536 | 0.100 |
Why?
|
Body Weight | 7 | 2013 | 4669 | 0.100 |
Why?
|
Radiotherapy | 3 | 2008 | 1533 | 0.100 |
Why?
|
Sequence Alignment | 3 | 2005 | 2256 | 0.100 |
Why?
|
Hypopituitarism | 4 | 2002 | 254 | 0.100 |
Why?
|
Blood Specimen Collection | 3 | 1999 | 246 | 0.100 |
Why?
|
Cross-Over Studies | 6 | 2014 | 2029 | 0.100 |
Why?
|
Infusions, Parenteral | 10 | 1986 | 419 | 0.100 |
Why?
|
Body Mass Index | 8 | 2013 | 12720 | 0.090 |
Why?
|
Gene Expression Profiling | 2 | 2013 | 9438 | 0.090 |
Why?
|
Galactorrhea | 2 | 1980 | 24 | 0.090 |
Why?
|
Cushing Syndrome | 3 | 2000 | 249 | 0.090 |
Why?
|
Lactation Disorders | 2 | 1980 | 16 | 0.090 |
Why?
|
Incidental Findings | 1 | 2015 | 689 | 0.090 |
Why?
|
Substance Abuse Detection | 1 | 2013 | 283 | 0.090 |
Why?
|
O(6)-Methylguanine-DNA Methyltransferase | 1 | 2010 | 85 | 0.090 |
Why?
|
Mutation, Missense | 1 | 1999 | 2564 | 0.090 |
Why?
|
Biological Assay | 3 | 2011 | 652 | 0.090 |
Why?
|
Immunosorbent Techniques | 3 | 1999 | 184 | 0.090 |
Why?
|
Time Factors | 25 | 2008 | 40075 | 0.090 |
Why?
|
Genes | 1 | 1994 | 1893 | 0.090 |
Why?
|
Appetite | 2 | 2008 | 243 | 0.090 |
Why?
|
Drug Therapy, Combination | 2 | 2018 | 6489 | 0.090 |
Why?
|
Cholinesterases | 1 | 2009 | 34 | 0.090 |
Why?
|
Sensory Receptor Cells | 1 | 2014 | 492 | 0.090 |
Why?
|
Metabolism | 1 | 2010 | 196 | 0.090 |
Why?
|
Hydroxybutyrates | 3 | 1997 | 82 | 0.090 |
Why?
|
Acyl-CoA Oxidase | 1 | 2008 | 9 | 0.090 |
Why?
|
Aged, 80 and over | 15 | 2008 | 57776 | 0.080 |
Why?
|
Stimulation, Chemical | 4 | 2001 | 326 | 0.080 |
Why?
|
Plant Oils | 1 | 2010 | 202 | 0.080 |
Why?
|
Molecular Sequence Data | 5 | 2005 | 18111 | 0.080 |
Why?
|
Calcium | 5 | 1991 | 5756 | 0.080 |
Why?
|
Europe | 1 | 2015 | 3339 | 0.080 |
Why?
|
Multiple Endocrine Neoplasia | 1 | 1988 | 25 | 0.080 |
Why?
|
3-Hydroxybutyric Acid | 3 | 2005 | 87 | 0.080 |
Why?
|
Mice, Knockout | 5 | 2013 | 14557 | 0.080 |
Why?
|
Endocrine System Diseases | 2 | 1988 | 248 | 0.080 |
Why?
|
Glycosylation | 3 | 1999 | 1126 | 0.080 |
Why?
|
Amenorrhea | 3 | 1985 | 485 | 0.080 |
Why?
|
Estrus | 2 | 1991 | 81 | 0.080 |
Why?
|
Butyrylcholinesterase | 1 | 2008 | 22 | 0.080 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2008 | 137 | 0.080 |
Why?
|
Chromatography, Gel | 5 | 1990 | 668 | 0.080 |
Why?
|
Hypothalamo-Hypophyseal System | 4 | 2008 | 703 | 0.080 |
Why?
|
Metabolic Clearance Rate | 6 | 1996 | 380 | 0.080 |
Why?
|
Anorexia | 1 | 2008 | 161 | 0.080 |
Why?
|
Drug Administration Schedule | 6 | 2001 | 4933 | 0.080 |
Why?
|
Immune Sera | 1 | 2008 | 641 | 0.080 |
Why?
|
Immunoradiometric Assay | 4 | 2001 | 24 | 0.080 |
Why?
|
DNA Primers | 2 | 2007 | 2892 | 0.080 |
Why?
|
Thigh | 1 | 2008 | 247 | 0.070 |
Why?
|
Growth | 3 | 1992 | 376 | 0.070 |
Why?
|
Dacarbazine | 1 | 2010 | 566 | 0.070 |
Why?
|
Lactones | 1 | 2010 | 329 | 0.070 |
Why?
|
PPAR alpha | 1 | 2008 | 197 | 0.070 |
Why?
|
Postmenopause | 1 | 1996 | 2461 | 0.070 |
Why?
|
Dopamine | 2 | 1987 | 1591 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2010 | 3870 | 0.070 |
Why?
|
Succinimides | 1 | 1986 | 79 | 0.070 |
Why?
|
Leptin | 4 | 2009 | 1599 | 0.070 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2023 | 11725 | 0.070 |
Why?
|
Cachexia | 1 | 2008 | 204 | 0.070 |
Why?
|
Octreotide | 3 | 2008 | 145 | 0.070 |
Why?
|
Carcinoid Tumor | 3 | 1991 | 235 | 0.070 |
Why?
|
Glucose Clamp Technique | 3 | 2010 | 266 | 0.070 |
Why?
|
Lymphocytes | 1 | 1994 | 2617 | 0.070 |
Why?
|
Polymerase Chain Reaction | 4 | 2010 | 6171 | 0.070 |
Why?
|
Sex Characteristics | 5 | 2007 | 2585 | 0.070 |
Why?
|
Base Sequence | 3 | 2005 | 12797 | 0.070 |
Why?
|
Neuropeptides | 1 | 1992 | 942 | 0.070 |
Why?
|
Homozygote | 2 | 2008 | 1785 | 0.070 |
Why?
|
Interferon-gamma | 1 | 1994 | 3206 | 0.070 |
Why?
|
Gene Expression Regulation | 2 | 2004 | 12072 | 0.070 |
Why?
|
Hypoglycemic Agents | 1 | 2018 | 2872 | 0.070 |
Why?
|
Contraceptive Agents, Female | 1 | 1987 | 135 | 0.070 |
Why?
|
Pituitary ACTH Hypersecretion | 1 | 2007 | 175 | 0.070 |
Why?
|
Feedback | 2 | 2000 | 795 | 0.060 |
Why?
|
3T3 Cells | 1 | 2007 | 1101 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1994 | 2455 | 0.060 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 3 | 2008 | 216 | 0.060 |
Why?
|
Glucose Tolerance Test | 7 | 2007 | 1150 | 0.060 |
Why?
|
Amino Acid Sequence | 5 | 2001 | 13815 | 0.060 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2007 | 563 | 0.060 |
Why?
|
Glutamate-Ammonia Ligase | 1 | 2004 | 74 | 0.060 |
Why?
|
DNA, Complementary | 2 | 2001 | 2050 | 0.060 |
Why?
|
Trans-Activators | 1 | 1994 | 2924 | 0.060 |
Why?
|
Growth Substances | 1 | 2007 | 784 | 0.060 |
Why?
|
Area Under Curve | 3 | 2008 | 1654 | 0.060 |
Why?
|
Cells, Cultured | 11 | 2008 | 19229 | 0.060 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 1790 | 0.060 |
Why?
|
Child Development | 1 | 1996 | 2223 | 0.060 |
Why?
|
Administration, Intranasal | 4 | 1986 | 446 | 0.060 |
Why?
|
Mice, Inbred C3H | 1 | 2005 | 964 | 0.060 |
Why?
|
DNA, Recombinant | 1 | 2004 | 476 | 0.060 |
Why?
|
Glycoside Hydrolases | 2 | 1994 | 133 | 0.060 |
Why?
|
Subcutaneous Tissue | 1 | 2004 | 135 | 0.060 |
Why?
|
Single-Blind Method | 3 | 2014 | 1590 | 0.060 |
Why?
|
Prefrontal Cortex | 1 | 2014 | 2147 | 0.060 |
Why?
|
Phosphotyrosine | 2 | 1994 | 457 | 0.060 |
Why?
|
Antibodies | 2 | 1996 | 2460 | 0.050 |
Why?
|
Dietary Carbohydrates | 1 | 2008 | 906 | 0.050 |
Why?
|
Radiosurgery | 3 | 2016 | 1329 | 0.050 |
Why?
|
Sex Factors | 9 | 2005 | 10397 | 0.050 |
Why?
|
Dietary Proteins | 1 | 2008 | 963 | 0.050 |
Why?
|
Sensitivity and Specificity | 5 | 2010 | 14722 | 0.050 |
Why?
|
Calcium Channel Blockers | 2 | 1985 | 690 | 0.050 |
Why?
|
Sleep | 6 | 1998 | 4623 | 0.050 |
Why?
|
Infusion Pumps | 2 | 1996 | 163 | 0.050 |
Why?
|
Cranial Irradiation | 1 | 2005 | 401 | 0.050 |
Why?
|
Sequence Analysis, DNA | 2 | 2005 | 4803 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 1994 | 4554 | 0.050 |
Why?
|
Carrier Proteins | 3 | 1998 | 5021 | 0.050 |
Why?
|
Muscles | 1 | 2007 | 1614 | 0.050 |
Why?
|
Blood Vessels | 1 | 2008 | 1125 | 0.050 |
Why?
|
Glucose | 4 | 2010 | 4397 | 0.050 |
Why?
|
Signal Transduction | 8 | 2013 | 23403 | 0.050 |
Why?
|
Mice, Inbred C57BL | 3 | 2013 | 21827 | 0.050 |
Why?
|
Hippocampus | 1 | 2014 | 3675 | 0.050 |
Why?
|
Acetoacetates | 2 | 1993 | 22 | 0.050 |
Why?
|
Energy Metabolism | 1 | 2013 | 2899 | 0.050 |
Why?
|
Prolactinoma | 2 | 2004 | 113 | 0.050 |
Why?
|
Bone Density Conservation Agents | 1 | 2008 | 773 | 0.050 |
Why?
|
Photoaffinity Labels | 1 | 2001 | 86 | 0.050 |
Why?
|
Child, Preschool | 8 | 2015 | 41006 | 0.050 |
Why?
|
Blotting, Western | 3 | 1999 | 5179 | 0.050 |
Why?
|
Rats, Inbred WF | 1 | 2000 | 140 | 0.050 |
Why?
|
Injections, Intraventricular | 1 | 2000 | 230 | 0.050 |
Why?
|
Pediatrics | 1 | 2015 | 3475 | 0.050 |
Why?
|
Binding, Competitive | 2 | 1994 | 1157 | 0.040 |
Why?
|
Dietary Fats | 1 | 2008 | 2017 | 0.040 |
Why?
|
Disease Progression | 2 | 2015 | 13284 | 0.040 |
Why?
|
Drug Interactions | 3 | 1992 | 1460 | 0.040 |
Why?
|
Thymus Neoplasms | 1 | 1982 | 268 | 0.040 |
Why?
|
Up-Regulation | 1 | 2008 | 4217 | 0.040 |
Why?
|
Diabetes, Gestational | 1 | 2009 | 1184 | 0.040 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1999 | 428 | 0.040 |
Why?
|
Pituitary-Adrenal System | 1 | 2002 | 553 | 0.040 |
Why?
|
Corticotropin-Releasing Hormone | 3 | 1985 | 369 | 0.040 |
Why?
|
Atenolol | 2 | 1990 | 100 | 0.040 |
Why?
|
Molecular Weight | 2 | 1993 | 2255 | 0.040 |
Why?
|
Models, Biological | 2 | 2007 | 9583 | 0.040 |
Why?
|
Receptors, Somatostatin | 1 | 1998 | 129 | 0.040 |
Why?
|
Phosphoproteins | 1 | 2007 | 2440 | 0.040 |
Why?
|
Body Height | 1 | 1984 | 1577 | 0.040 |
Why?
|
Nervous System Diseases | 1 | 1988 | 1622 | 0.040 |
Why?
|
Sleep, REM | 3 | 1996 | 595 | 0.040 |
Why?
|
Hypothalamic Hormones | 1 | 1998 | 147 | 0.040 |
Why?
|
Histocytochemistry | 4 | 2007 | 719 | 0.040 |
Why?
|
Pituitary Function Tests | 3 | 1985 | 27 | 0.040 |
Why?
|
Weight Loss | 1 | 2008 | 2622 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 1994 | 9648 | 0.040 |
Why?
|
Brain Neoplasms | 3 | 2008 | 8863 | 0.040 |
Why?
|
MicroRNAs | 1 | 2013 | 3752 | 0.040 |
Why?
|
Phosphorylation | 3 | 2008 | 8436 | 0.040 |
Why?
|
Islets of Langerhans | 1 | 1983 | 1352 | 0.040 |
Why?
|
Cluster Analysis | 3 | 2007 | 2715 | 0.030 |
Why?
|
Thyroid Gland | 1 | 2023 | 1173 | 0.030 |
Why?
|
Cell Line | 4 | 1994 | 15997 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2000 | 2085 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 6 | 2015 | 35421 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 2 | 2000 | 8301 | 0.030 |
Why?
|
Regression Analysis | 4 | 2001 | 6459 | 0.030 |
Why?
|
Adrenal Cortex | 1 | 1996 | 140 | 0.030 |
Why?
|
Pancreas | 1 | 1983 | 1686 | 0.030 |
Why?
|
Hemolytic Plaque Technique | 4 | 1988 | 66 | 0.030 |
Why?
|
Algorithms | 2 | 2009 | 13881 | 0.030 |
Why?
|
Hypothyroidism | 3 | 2004 | 658 | 0.030 |
Why?
|
Regional Blood Flow | 2 | 2010 | 1525 | 0.030 |
Why?
|
Treatment Outcome | 6 | 2016 | 63114 | 0.030 |
Why?
|
Iodine Radioisotopes | 1 | 1999 | 1032 | 0.030 |
Why?
|
Ergot Alkaloids | 1 | 1975 | 12 | 0.030 |
Why?
|
Immunoassay | 1 | 1999 | 752 | 0.030 |
Why?
|
Diestrus | 2 | 1986 | 8 | 0.030 |
Why?
|
Clinical Medicine | 1 | 1997 | 147 | 0.030 |
Why?
|
Estrone | 1 | 1996 | 240 | 0.030 |
Why?
|
Gonadotropins | 1 | 1996 | 241 | 0.030 |
Why?
|
Glycoprotein Hormones, alpha Subunit | 2 | 1985 | 98 | 0.030 |
Why?
|
Age Factors | 5 | 2005 | 18370 | 0.030 |
Why?
|
Cholic Acids | 1 | 1994 | 41 | 0.030 |
Why?
|
Vitamin D | 1 | 2008 | 3223 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2016 | 77449 | 0.030 |
Why?
|
Janus Kinase 1 | 1 | 1994 | 104 | 0.030 |
Why?
|
Receptors, Interferon | 1 | 1994 | 115 | 0.030 |
Why?
|
Reserpine | 2 | 1985 | 66 | 0.030 |
Why?
|
Microscopy, Electron | 3 | 2000 | 2645 | 0.030 |
Why?
|
Neuraminidase | 1 | 1994 | 210 | 0.030 |
Why?
|
Administration, Cutaneous | 1 | 1996 | 711 | 0.030 |
Why?
|
Hybrid Cells | 1 | 1994 | 441 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 1999 | 3129 | 0.030 |
Why?
|
Carbohydrate Conformation | 1 | 1993 | 208 | 0.030 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 1996 | 548 | 0.030 |
Why?
|
Models, Animal | 2 | 2012 | 2171 | 0.030 |
Why?
|
STAT1 Transcription Factor | 1 | 1994 | 320 | 0.030 |
Why?
|
Thyroxine | 3 | 1987 | 667 | 0.030 |
Why?
|
Receptor, Melanocortin, Type 3 | 1 | 2013 | 15 | 0.030 |
Why?
|
Pain | 1 | 2008 | 4986 | 0.030 |
Why?
|
Insulin Resistance | 1 | 2007 | 3864 | 0.030 |
Why?
|
Biological Transport, Active | 1 | 1993 | 349 | 0.030 |
Why?
|
Abdomen | 2 | 2014 | 1118 | 0.030 |
Why?
|
Doping in Sports | 1 | 2013 | 63 | 0.030 |
Why?
|
Postprandial Period | 1 | 2014 | 292 | 0.030 |
Why?
|
Placebos | 2 | 2009 | 1676 | 0.030 |
Why?
|
Pregnancy | 8 | 2009 | 29144 | 0.030 |
Why?
|
Hyperplasia | 4 | 1984 | 1185 | 0.030 |
Why?
|
Agouti-Related Protein | 1 | 2013 | 98 | 0.030 |
Why?
|
Clinical Trials as Topic | 4 | 2016 | 7913 | 0.030 |
Why?
|
Physical Endurance | 2 | 2004 | 370 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2000 | 6314 | 0.030 |
Why?
|
Dehydroepiandrosterone Sulfate | 2 | 1996 | 238 | 0.030 |
Why?
|
Lactation | 2 | 1985 | 412 | 0.030 |
Why?
|
Luteal Phase | 2 | 1984 | 147 | 0.030 |
Why?
|
Dehydroepiandrosterone | 2 | 1996 | 252 | 0.030 |
Why?
|
Verapamil | 3 | 1988 | 244 | 0.020 |
Why?
|
Turner Syndrome | 2 | 1982 | 130 | 0.020 |
Why?
|
Janus Kinase 2 | 1 | 1994 | 528 | 0.020 |
Why?
|
Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 1992 | 102 | 0.020 |
Why?
|
Cell Membrane | 2 | 1999 | 3748 | 0.020 |
Why?
|
Carbohydrate Metabolism | 1 | 1992 | 264 | 0.020 |
Why?
|
Palmitates | 1 | 2010 | 74 | 0.020 |
Why?
|
Patient Selection | 1 | 2003 | 4215 | 0.020 |
Why?
|
Infusions, Intra-Arterial | 1 | 2010 | 234 | 0.020 |
Why?
|
Food Preferences | 1 | 2014 | 399 | 0.020 |
Why?
|
Cell Compartmentation | 1 | 1991 | 402 | 0.020 |
Why?
|
Castration | 2 | 1992 | 159 | 0.020 |
Why?
|
Physical Exertion | 2 | 2001 | 695 | 0.020 |
Why?
|
Forecasting | 2 | 1997 | 2951 | 0.020 |
Why?
|
Lipids | 2 | 2004 | 3305 | 0.020 |
Why?
|
Brain | 1 | 2017 | 26385 | 0.020 |
Why?
|
Cricetinae | 1 | 1994 | 2472 | 0.020 |
Why?
|
Lactates | 1 | 2010 | 432 | 0.020 |
Why?
|
Perfusion | 2 | 1985 | 1360 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Protein 2 | 2 | 2001 | 76 | 0.020 |
Why?
|
Quality of Life | 2 | 2008 | 12804 | 0.020 |
Why?
|
Proteins | 2 | 1997 | 6103 | 0.020 |
Why?
|
Lipolysis | 1 | 2010 | 210 | 0.020 |
Why?
|
Propranolol | 3 | 1987 | 502 | 0.020 |
Why?
|
Antibodies, Monoclonal | 2 | 1999 | 9274 | 0.020 |
Why?
|
Peptides | 4 | 1990 | 4409 | 0.020 |
Why?
|
Leukemia | 2 | 2008 | 1511 | 0.020 |
Why?
|
Indicators and Reagents | 1 | 2010 | 462 | 0.020 |
Why?
|
Basal Metabolism | 1 | 1990 | 168 | 0.020 |
Why?
|
Indocyanine Green | 1 | 2010 | 239 | 0.020 |
Why?
|
Genetic Variation | 1 | 2004 | 6544 | 0.020 |
Why?
|
Drug Synergism | 2 | 1990 | 1792 | 0.020 |
Why?
|
Immunohistochemistry | 4 | 2010 | 11366 | 0.020 |
Why?
|
Alzheimer Disease | 1 | 1989 | 8037 | 0.020 |
Why?
|
Exons | 1 | 1994 | 2437 | 0.020 |
Why?
|
Wakefulness | 2 | 1992 | 1245 | 0.020 |
Why?
|
Visual Fields | 2 | 1985 | 1047 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1993 | 2839 | 0.020 |
Why?
|
Clonidine | 2 | 1988 | 164 | 0.020 |
Why?
|
Coloring Agents | 1 | 2010 | 566 | 0.020 |
Why?
|
Macaca fascicularis | 2 | 1987 | 915 | 0.020 |
Why?
|
Phenylalanine | 1 | 2009 | 365 | 0.020 |
Why?
|
Follow-Up Studies | 5 | 2011 | 39050 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2013 | 970 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 1993 | 1701 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 1994 | 2649 | 0.020 |
Why?
|
Adrenal Cortex Function Tests | 1 | 2007 | 13 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 1993 | 1758 | 0.020 |
Why?
|
Urea | 1 | 2009 | 450 | 0.020 |
Why?
|
Analysis of Variance | 3 | 1994 | 6365 | 0.020 |
Why?
|
Drug Tolerance | 1 | 1989 | 376 | 0.020 |
Why?
|
Protein Transport | 1 | 2013 | 1988 | 0.020 |
Why?
|
Pulse | 1 | 1987 | 229 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 1995 | 12959 | 0.020 |
Why?
|
Pregnancy Trimester, Third | 1 | 2009 | 571 | 0.020 |
Why?
|
Femoral Artery | 1 | 2010 | 845 | 0.020 |
Why?
|
United States | 3 | 1999 | 69872 | 0.020 |
Why?
|
Hydroxyproline | 2 | 1976 | 116 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2004 | 18029 | 0.020 |
Why?
|
Remission Induction | 1 | 2011 | 2386 | 0.020 |
Why?
|
Methyldopa | 1 | 1985 | 20 | 0.020 |
Why?
|
Syndrome | 2 | 2002 | 3251 | 0.020 |
Why?
|
Puberty | 1 | 1989 | 490 | 0.020 |
Why?
|
Leg | 1 | 2010 | 1116 | 0.020 |
Why?
|
Forearm | 1 | 2008 | 409 | 0.020 |
Why?
|
Transfection | 1 | 1993 | 5892 | 0.020 |
Why?
|
Androgens | 1 | 1993 | 1281 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 1994 | 4740 | 0.020 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 1987 | 255 | 0.020 |
Why?
|
Nifedipine | 1 | 1985 | 226 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 1987 | 440 | 0.020 |
Why?
|
Receptors, Adrenergic, beta | 1 | 1985 | 246 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2008 | 689 | 0.020 |
Why?
|
Hypothalamic Neoplasms | 1 | 1984 | 22 | 0.020 |
Why?
|
Chromatography | 1 | 1984 | 206 | 0.020 |
Why?
|
Depressive Disorder | 2 | 1988 | 3748 | 0.020 |
Why?
|
Median Eminence | 1 | 1984 | 37 | 0.020 |
Why?
|
Isoelectric Focusing | 1 | 1984 | 181 | 0.020 |
Why?
|
Diltiazem | 1 | 1985 | 133 | 0.020 |
Why?
|
Beverages | 1 | 2010 | 820 | 0.020 |
Why?
|
Levodopa | 1 | 1985 | 219 | 0.010 |
Why?
|
Gallopamil | 1 | 1983 | 6 | 0.010 |
Why?
|
Homeostasis | 2 | 1992 | 3340 | 0.010 |
Why?
|
Calmodulin | 1 | 1984 | 209 | 0.010 |
Why?
|
Growth Plate | 1 | 1986 | 274 | 0.010 |
Why?
|
Bilirubin | 1 | 2005 | 425 | 0.010 |
Why?
|
Fibrous Dysplasia, Polyostotic | 1 | 1984 | 36 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 1992 | 3336 | 0.010 |
Why?
|
Cycloheximide | 1 | 1984 | 347 | 0.010 |
Why?
|
Cohort Studies | 3 | 2001 | 40561 | 0.010 |
Why?
|
Fibrous Dysplasia of Bone | 1 | 1984 | 54 | 0.010 |
Why?
|
Nitrogen | 1 | 1985 | 344 | 0.010 |
Why?
|
Proestrus | 1 | 1983 | 19 | 0.010 |
Why?
|
Secretory Rate | 1 | 1983 | 82 | 0.010 |
Why?
|
Granulomatous Disease, Chronic | 1 | 2004 | 174 | 0.010 |
Why?
|
Absorptiometry, Photon | 2 | 2001 | 1725 | 0.010 |
Why?
|
Dyskinesia, Drug-Induced | 1 | 1984 | 163 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 1988 | 1677 | 0.010 |
Why?
|
Diterpenes | 1 | 1984 | 173 | 0.010 |
Why?
|
In Situ Hybridization | 2 | 1997 | 1950 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 1992 | 1889 | 0.010 |
Why?
|
Premenstrual Syndrome | 1 | 1984 | 109 | 0.010 |
Why?
|
Immunoenzyme Techniques | 2 | 1985 | 1799 | 0.010 |
Why?
|
Adiponectin | 1 | 2009 | 1100 | 0.010 |
Why?
|
Hepatic Encephalopathy | 1 | 1984 | 139 | 0.010 |
Why?
|
Graves Disease | 1 | 2004 | 242 | 0.010 |
Why?
|
17-Ketosteroids | 1 | 1982 | 39 | 0.010 |
Why?
|
17-Hydroxycorticosteroids | 1 | 1982 | 40 | 0.010 |
Why?
|
RNA | 1 | 1993 | 2749 | 0.010 |
Why?
|
Neoplasms | 3 | 2005 | 21683 | 0.010 |
Why?
|
Postpartum Period | 1 | 2009 | 1086 | 0.010 |
Why?
|
Pergolide | 1 | 1981 | 3 | 0.010 |
Why?
|
Preoperative Care | 1 | 1991 | 2250 | 0.010 |
Why?
|
Adiposity | 1 | 2012 | 1807 | 0.010 |
Why?
|
Energy Intake | 1 | 2010 | 2148 | 0.010 |
Why?
|
Carcinoma, Small Cell | 1 | 1984 | 420 | 0.010 |
Why?
|
Metabolism, Inborn Errors | 1 | 2004 | 288 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1984 | 1801 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 5 | 2001 | 20129 | 0.010 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 1983 | 171 | 0.010 |
Why?
|
Cholera Toxin | 1 | 1984 | 556 | 0.010 |
Why?
|
Gene Expression | 1 | 1994 | 7799 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 1987 | 1240 | 0.010 |
Why?
|
Menstrual Cycle | 1 | 1984 | 551 | 0.010 |
Why?
|
Viscera | 1 | 2001 | 139 | 0.010 |
Why?
|
Running | 1 | 1985 | 480 | 0.010 |
Why?
|
Least-Squares Analysis | 1 | 2001 | 379 | 0.010 |
Why?
|
Fetal Growth Retardation | 1 | 1984 | 570 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 4042 | 0.010 |
Why?
|
Thermodynamics | 1 | 2002 | 596 | 0.010 |
Why?
|
Adenoma, Acidophil | 1 | 1980 | 3 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2013 | 3188 | 0.010 |
Why?
|
Giant Cell Arteritis | 1 | 2004 | 292 | 0.010 |
Why?
|
Antibody Formation | 1 | 1985 | 1402 | 0.010 |
Why?
|
Research Design | 1 | 2016 | 5987 | 0.010 |
Why?
|
Culture Media | 1 | 1982 | 908 | 0.010 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2008 | 1524 | 0.010 |
Why?
|
Lipoproteins, HDL | 1 | 1984 | 638 | 0.010 |
Why?
|
Diagnostic Techniques, Endocrine | 1 | 1999 | 45 | 0.010 |
Why?
|
Malignant Carcinoid Syndrome | 1 | 1979 | 31 | 0.010 |
Why?
|
Edema | 1 | 1984 | 789 | 0.010 |
Why?
|
Anthropometry | 1 | 2004 | 1350 | 0.010 |
Why?
|
Lymphoma | 1 | 2008 | 1877 | 0.010 |
Why?
|
Steroids | 1 | 2004 | 930 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2008 | 2503 | 0.010 |
Why?
|
Entropy | 1 | 1999 | 209 | 0.010 |
Why?
|
Half-Life | 2 | 1991 | 661 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2010 | 5867 | 0.010 |
Why?
|
DNA | 1 | 1993 | 7301 | 0.010 |
Why?
|
Fura-2 | 2 | 1988 | 109 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 1995 | 7279 | 0.010 |
Why?
|
Bacterial Toxins | 1 | 1984 | 931 | 0.010 |
Why?
|
Cobalt | 2 | 1988 | 158 | 0.010 |
Why?
|
Radiography | 2 | 2001 | 7023 | 0.010 |
Why?
|
Kidney | 1 | 1993 | 7186 | 0.010 |
Why?
|
Benzofurans | 2 | 1988 | 140 | 0.010 |
Why?
|
Cholesterol, HDL | 1 | 1984 | 1814 | 0.010 |
Why?
|
Infertility, Female | 1 | 1984 | 787 | 0.010 |
Why?
|
Mutation | 1 | 2002 | 29786 | 0.010 |
Why?
|
Genotype | 1 | 2012 | 12951 | 0.010 |
Why?
|
Pedigree | 1 | 1985 | 4644 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 1981 | 2031 | 0.010 |
Why?
|
Thymus Gland | 1 | 1982 | 1267 | 0.010 |
Why?
|
Huntington Disease | 1 | 1984 | 1124 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2007 | 6538 | 0.010 |
Why?
|
Insulin-Like Growth Factor II | 1 | 1998 | 271 | 0.010 |
Why?
|
Intestines | 1 | 1986 | 1924 | 0.010 |
Why?
|
Drug Evaluation | 1 | 1978 | 647 | 0.010 |
Why?
|
Survivors | 1 | 2007 | 2291 | 0.010 |
Why?
|
Triglycerides | 1 | 1984 | 2454 | 0.010 |
Why?
|
Peptic Ulcer | 1 | 1978 | 223 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2008 | 21746 | 0.010 |
Why?
|
DNA Methylation | 1 | 2010 | 4286 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8642 | 0.010 |
Why?
|
Drug Resistance | 1 | 2002 | 1609 | 0.010 |
Why?
|
Recurrence | 1 | 2007 | 8340 | 0.010 |
Why?
|
Progesterone | 1 | 1980 | 776 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1997 | 1581 | 0.010 |
Why?
|
Drug Monitoring | 1 | 2002 | 956 | 0.010 |
Why?
|
Fetal Blood | 1 | 1982 | 1318 | 0.010 |
Why?
|
Bromine | 1 | 1975 | 23 | 0.010 |
Why?
|
Zollinger-Ellison Syndrome | 1 | 1974 | 15 | 0.010 |
Why?
|
Cell Survival | 1 | 1985 | 5882 | 0.010 |
Why?
|
Ki-67 Antigen | 1 | 1997 | 644 | 0.010 |
Why?
|
Cholesterol | 1 | 1984 | 2917 | 0.010 |
Why?
|
Phenotype | 1 | 2013 | 16365 | 0.010 |
Why?
|
Gastrins | 1 | 1974 | 81 | 0.010 |
Why?
|
Gastric Juice | 1 | 1974 | 63 | 0.010 |
Why?
|
Anemia, Pernicious | 1 | 1974 | 19 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2008 | 3479 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2001 | 2886 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2012 | 7880 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 2001 | 1869 | 0.010 |
Why?
|
Nausea | 1 | 1978 | 673 | 0.010 |
Why?
|
Software | 1 | 2009 | 4443 | 0.010 |
Why?
|
Sweating | 1 | 1975 | 123 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 1984 | 2046 | 0.010 |
Why?
|
Ion Channels | 2 | 1988 | 1056 | 0.010 |
Why?
|
Models, Statistical | 1 | 1988 | 5102 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 1985 | 2538 | 0.010 |
Why?
|
Feminization | 1 | 1992 | 23 | 0.010 |
Why?
|
Autoantibodies | 1 | 2000 | 2035 | 0.010 |
Why?
|
Microscopy, Fluorescence | 2 | 1988 | 2699 | 0.010 |
Why?
|
Insulin Infusion Systems | 1 | 1992 | 212 | 0.010 |
Why?
|
Fluorescent Dyes | 2 | 1988 | 1917 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 1999 | 2716 | 0.010 |
Why?
|
Age Determination by Skeleton | 1 | 1990 | 129 | 0.010 |
Why?
|
Lung Neoplasms | 2 | 1991 | 13102 | 0.010 |
Why?
|
Silicone Elastomers | 1 | 1988 | 84 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2009 | 25625 | 0.010 |
Why?
|
Hyperinsulinism | 1 | 1992 | 415 | 0.010 |
Why?
|
Receptors, Adrenergic, alpha | 1 | 1988 | 149 | 0.000 |
Why?
|
Statistics as Topic | 1 | 1994 | 2373 | 0.000 |
Why?
|
Dextroamphetamine | 1 | 1988 | 129 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2010 | 13695 | 0.000 |
Why?
|
Exocytosis | 1 | 1988 | 353 | 0.000 |
Why?
|
Organ Size | 1 | 1992 | 2252 | 0.000 |
Why?
|
Orchiectomy | 1 | 1988 | 474 | 0.000 |
Why?
|
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 1985 | 36 | 0.000 |
Why?
|
Ovariectomy | 1 | 1988 | 661 | 0.000 |
Why?
|
Isoproterenol | 1 | 1985 | 399 | 0.000 |
Why?
|
Models, Theoretical | 1 | 1997 | 3589 | 0.000 |
Why?
|
Cytosol | 1 | 1988 | 901 | 0.000 |
Why?
|
Calcimycin | 1 | 1984 | 222 | 0.000 |
Why?
|
ACTH Syndrome, Ectopic | 1 | 1984 | 30 | 0.000 |
Why?
|
Inflammation | 1 | 2004 | 10638 | 0.000 |
Why?
|
Pancreatic Juice | 1 | 1984 | 62 | 0.000 |
Why?
|
Prospective Studies | 1 | 2009 | 53288 | 0.000 |
Why?
|
Virulence Factors, Bordetella | 1 | 1984 | 156 | 0.000 |
Why?
|
Methods | 1 | 1984 | 1129 | 0.000 |
Why?
|
Pertussis Toxin | 1 | 1984 | 178 | 0.000 |
Why?
|
Mental Disorders | 1 | 1984 | 6600 | 0.000 |
Why?
|
Triiodothyronine | 1 | 1985 | 494 | 0.000 |
Why?
|
Cyanogen Bromide | 1 | 1982 | 73 | 0.000 |
Why?
|
Logistic Models | 1 | 1998 | 13408 | 0.000 |
Why?
|
Bucladesine | 1 | 1982 | 121 | 0.000 |
Why?
|
Prostaglandins E | 1 | 1982 | 172 | 0.000 |
Why?
|
Norepinephrine | 1 | 1985 | 909 | 0.000 |
Why?
|
Alprostadil | 1 | 1982 | 89 | 0.000 |
Why?
|
Hyperglycemia | 1 | 1992 | 1373 | 0.000 |
Why?
|
Pheochromocytoma | 1 | 1985 | 337 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 1998 | 15076 | 0.000 |
Why?
|
Epinephrine | 1 | 1985 | 792 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2004 | 15295 | 0.000 |
Why?
|
Veins | 1 | 1984 | 770 | 0.000 |
Why?
|
Adrenal Gland Neoplasms | 1 | 1985 | 740 | 0.000 |
Why?
|
Digestive System Surgical Procedures | 1 | 1984 | 576 | 0.000 |
Why?
|
Radiotherapy, High-Energy | 1 | 1979 | 228 | 0.000 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1997 | 9239 | 0.000 |
Why?
|
Potassium | 1 | 1982 | 1336 | 0.000 |
Why?
|
Prognosis | 1 | 1997 | 29063 | 0.000 |
Why?
|
Swine | 1 | 1985 | 5917 | 0.000 |
Why?
|
Chlorpropamide | 1 | 1974 | 9 | 0.000 |
Why?
|
Paraneoplastic Endocrine Syndromes | 1 | 1974 | 31 | 0.000 |
Why?
|
Sulfonamides | 1 | 1984 | 1938 | 0.000 |
Why?
|
Risk Factors | 1 | 2002 | 72290 | 0.000 |
Why?
|
Computer Simulation | 1 | 1988 | 6196 | 0.000 |
Why?
|
Injections, Intramuscular | 1 | 1974 | 552 | 0.000 |
Why?
|
Thyroid Neoplasms | 1 | 1985 | 2282 | 0.000 |
Why?
|
Catheterization | 1 | 1974 | 1470 | 0.000 |
Why?
|
Diabetes Complications | 1 | 1974 | 1359 | 0.000 |
Why?
|
Infant | 1 | 1986 | 35136 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 1984 | 11124 | 0.000 |
Why?
|